Market News AIOpen the app

Barclays changes its price goal for Axogen to $50 from $55.

OpinionRead the original at moomoo.com
Neutral

Barclays lowered its share target but kept its positive rating. Those opposing signals do not show a clear change in Axogen's business outlook.

AXGN · Axogen, Inc.

AI read · Neutral

The AI's read

The lower target signals Barclays sees less room for Axogen shares to rise than before. Keeping its positive rating points the other way. The story reports no new company results, so these mixed signals do not clearly change Axogen's outlook.

Get alerts for AXGN

Follow Axogen, Inc. (AXGN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for AXGN
Free on the App Store and Google Play, or on the web.